Goran C Sedvall
Overview
Explore the profile of Goran C Sedvall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hjarpe J, Soderman E, Andreou D, Sedvall G, Agartz I, Jonsson E
Psychiatry Res
. 2018 Feb;
263:30-34.
PMID: 29482043
Metabolism of the monoamines dopamine, serotonin and noradrenaline, is altered in the central nervous system of people with schizophrenia, and their major metabolites homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and...
2.
Andreou D, Soderman E, Axelsson T, Sedvall G, Terenius L, Agartz I, et al.
Neurosci Lett
. 2016 Mar;
619:126-30.
PMID: 26957229
Dopamine activity, mediated by the catecholaminergic neurotransmitter dopamine, is prominent in the human brain and has been implicated in schizophrenia. Dopamine targets five different receptors and is then degraded to...
3.
Andreou D, Soderman E, Axelsson T, Sedvall G, Terenius L, Agartz I, et al.
Psychiatry Res
. 2015 Jul;
229(1-2):497-504.
PMID: 26142836
Glutamate-related genes have been associated with schizophrenia, but the results have been ambiguous and difficult to replicate. Homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are the major degradation...
4.
Andreou D, Soderman E, Axelsson T, Sedvall G, Terenius L, Agartz I, et al.
Behav Brain Funct
. 2014 Jul;
10:26.
PMID: 25073638
Background: Homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are the major monoamine metabolites in the central nervous system (CNS). Their cerebrospinal fluid (CSF) concentrations, reflecting the monoamine turnover...
5.
Andreou D, Saetre P, Werge T, Andreassen O, Agartz I, Sedvall G, et al.
Eur Arch Psychiatry Clin Neurosci
. 2012 Mar;
262(7):549-56.
PMID: 22454242
The D-amino acid oxidase activator (DAOA) protein regulates the function of D-amino oxidase (DAO), an enzyme that catalyzes the oxidative deamination of D-3,4-dihydroxyphenylalanine (D-DOPA) and D-serine. D-DOPA is converted to...
6.
Andreou D, Saetre P, Kahler A, Werge T, Andreassen O, Agartz I, et al.
Eur Neuropsychopharmacol
. 2011 Feb;
21(9):700-4.
PMID: 21295953
The dystrobrevin binding protein-1 (DTNBP1) gene encodes dysbindin-1, a protein involved in neurodevelopmental and neurochemical processes related mainly to the monoamine dopamine. We investigated possible associations between eleven DTNBP1 polymorphisms...
7.
Andreou D, Saetre P, Werge T, Andreassen O, Agartz I, Sedvall G, et al.
Psychiatry Res
. 2010 Jun;
180(2-3):63-7.
PMID: 20580984
Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin synthesis. We investigated possible relationships between five TPH1 gene polymorphisms and cerebrospinal fluid (CSF) concentrations of the major serotonin metabolite 5-hydroxyindoleacetic...
8.
Annerbrink K, Jonsson E, Olsson M, Nilsson S, Sedvall G, Anckarsater H, et al.
Psychiatry Res
. 2010 May;
179(2):231-4.
PMID: 20483169
Angiotensin II has been suggested to influence central dopamine and serotonin turnover. Since the angiotensin-converting enzyme (ACE) plays a key role in angiotensin regulation by converting inactive angiotensin I to...
9.
Vares M, Ekholm A, Sedvall G, Hall H, Jonsson E
Psychopathology
. 2006 Sep;
39(6):286-95.
PMID: 16960467
Background: We aimed at estimating the value of structured interviews, medical records and clinical diagnoses for assessing lifetime diagnosis of patients with schizophrenia. In addition, the validity of the Operational...
10.
Laywer G, Nyman H, Agartz I, Arnborg S, Jonsson E, Sedvall G, et al.
BMC Psychiatry
. 2006 Aug;
6:31.
PMID: 16901336
Background: Relationships between cognitive deficits and brain morphological changes observed in schizophrenia are alternately explained by less gray matter in the brain cerebral cortex, by alterations in neural circuitry involving...